Flechtner Jessica Baker

Avg. Two Year Performance

No purchase track record

50% Avg. Sale Return

22% Compound

	1 Mo	3 Mo	6 Mo	1 Yr	2 Yr
Average Purchase Return	--	--	--	--	--
Purchase Success Rate	--	--	--	--	--
Average Sale Return	8%	12%	24%	46%	50%
Sale Success Rate	7 of 11	6 of 11	9 of 11	9 of 11	9 of 11

Genocea Biosciences, Inc.

Drugs » Drugs - Generic

Chief Scientific Officer:

Holdings: 89.03K shares

Sentiment

Avg. Two Year Performance

No purchase track record

No sale track record

Last Three Months:

0 Net Amount

Buy:	0	--
Sell:	0	--